von Kutzleben, S., Pryce, G., Giovannoni, G., & Baker, D. (2017). Depletion of CD52‐positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune‐tolerance promoting CD8 T‐cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis. Immunology.
Čikaški stil citiranjavon Kutzleben, Stephanie, Gareth Pryce, Gavin Giovannoni, i David Baker. "Depletion of CD52‐positive Cells Inhibits the Development of Central Nervous System Autoimmune Disease, but Deletes an Immune‐tolerance Promoting CD8 T‐cell Population. Implications for Secondary Autoimmunity of Alemtuzumab in Multiple Sclerosis." Immunology 2017.
MLA način citiranjavon Kutzleben, Stephanie, Gareth Pryce, Gavin Giovannoni, i David Baker. "Depletion of CD52‐positive Cells Inhibits the Development of Central Nervous System Autoimmune Disease, but Deletes an Immune‐tolerance Promoting CD8 T‐cell Population. Implications for Secondary Autoimmunity of Alemtuzumab in Multiple Sclerosis." Immunology 2017.